Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Immatics US, Inc. is seeking a Principal Manager, Clinical Operations Lead to oversee US regional trials, manage CROs and vendors, and drive study execution from start‑up through delivery in a fast‑paced oncology program.
This fully remote role reports to the Associate Director, Clinical Asset Management. The ideal candidate has 7+ years in global clinical operations with leadership, vendor management, risk mitigation, and cross‑functional collaboration; mentoring CTMs, CRAs and CTAs while
Join Immatics and shape the future of cancer immunotherapy; one patient at a time! Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting‑edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T‑cell therapies and TCR bispecifics.
Why Join Us? Innovative Environment: Help to pioneer advancements in cancer immunotherapy. Collaborative Culture: Be part of a diverse team dedicated to your professional growth. Global Impact: Contribute to therapies that make a lasting impact on patients globally.
Role Overview We are seeking a Principal Manager, Clinical Operations Lead to support our Clinical Operations team. The Clinical Operations Lead will be responsible for the oversight, execution, and operational management of US regional clinical trials in support of our clinical development programs. Reports to: Associate Director, Clinical Asset Management Location: US, Fully Remote Salary Range: $165,000 - $180,000
Basic Qualifications: Bachelor’s degree in life science, nursing, or similar 7+ years of demonstrated leadership of global clinical operations in the pharmaceutical or biotechnology industry including clinical trial oversight, vendor management, and cross‑functional study leadership
Preferred Qualifications: Master’s Degree, preferably in life science, nursing, or similar Noted experience in late phase or launch in oncology. Experience cell and/or gene therapy, or other complex biologic clinical development programs Demonstrated ability to drive process improvements and operational excellence initiatives Ability to understand and navigate complex clinical development processes and cross‑functional interdependencies and collaborate with stakeholders outside of Clinical Operations Strong analytical and problem‑solving skills with the ability to assess operational impact across broader cross‑functional environments Ability to operate effectively in a fast‑paced and evolving clinical research environment
In this role you will:
What do we offer? At Immatics, we believe in investing in our team’s health, safety and well‑being. Here’s what you can expect if you join Immatics
Comprehensive Benefits:
Equal Employment Opportunity We are an equal opportunity employer and are committed to building a diverse and inclusive workplace. We consider all qualified applicants for employment without regard torace, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexualorientation, gender identity or expression, national origin, ancestry, age, marital status, disability, geneticinformation, veteran status, or any other status protected by applicable law.
Reasonable Accommodations We are committed to providing reasonable accommodations to individuals with disabilities and to applicants withsincerely heldreligious beliefs, practices, or observances.
Work Authorization Applicants mustbe authorized towork in the United States without the need for current or future sponsorship.
Pre-Employment Requirements Employment is contingent upon successful completion of a background check, referencechecksand pre‑employment drug screening, wherepermittedby applicable law. For certain roles,additionalscreenings such as a credit check or motor vehicle record review may berequired, where job‑related and consistent with business necessity.
We are committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting‑edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T‑cell therapies and TCR bispecifics.